Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
22.86
-0.26 (-1.12%)
Jul 24, 2026, 4:00 PM EDT - Market closed

Zymeworks Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
81.26105.9776.376.01412.4826.68
Revenue Growth
-12.98%38.87%0.38%-81.57%1446.03%-31.50%
Gross Profit
81.26105.9776.376.01412.4826.68
Operating Income
-114.05-92.55-137.11-138.05130.53-215.63
Net Income
-102.66-81.13-122.7-118.67124.34-211.84
Earnings Per Share
-1.37-1.08-1.62-1.721.90-4.61
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
364.73228.8225.78374.33492.23252.61
Total Debt
17.0418.2718.4826.6327.9932.23
Net Cash (Debt)
347.69210.53207.3347.7464.24220.38
Net Cash Growth
40.85%1.56%-40.38%-25.11%110.66%-47.26%
Net Cash Per Share
4.592.792.735.057.114.23

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-75.32-33.01-110.06-118.32144.11-192.45
Capital Expenditures
-1.72-1.52-1.99-2.47-8.15-12.4
Free Cash Flow
-77.04-34.53-112.05-120.8135.96-204.86
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-140.35%-87.34%-179.69%-181.62%31.64%-808.22%
Pretax Margin
-127.94%-75.26%-152.82%-156.87%32.79%-795.95%
Profit Margin
-126.33%-76.56%-160.80%-156.13%30.14%-794.01%
FCF Margin
-94.80%-32.58%-146.85%-158.92%32.96%-767.82%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----4.14-
Forward PE
25.685.435.435.4310.54-
P/FCF Ratio
----3.73-
PS Ratio
20.1418.6813.349.671.2328.65